Saturday, May 31, 2025
20.8 C
Bengaluru

Breaking Performance Barriers

[wpfilebase tag=file id=57 tpl=download-button /]

Inside this Issue

1. LinkedIn Leadership from K. Hariram

“How to lead a team of seniors” and “importance of keeping the ego in check when giving negative feedback” are issues covered in this edition.

2. Patient Access Part-III: Future of eHealthcare – Patient Convenience by Pankaj Mehrotra

Providing patients with an integrated health solution rather than just pills, is the future of pharma.

3. e-Pharmacies Are Here to Stay by Rinkesh Shah

Only a few compliance issues remain which can easily be ironed out. The consumer will benefit from this service.

4. Personalized Learning by Gopal Kishore

Using technology to make learning personalized is both cost effective and impactful.

5. What Barcodes Can Bring to Patient Support Programmes by Amaninder S Dhillon

Barcoding medicine packs can throw up valuable data for pharma companies while enhancing patient compliance.

6. Real World Data: A Primer by Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal and Mahendra Kumar Rai

Unlike experimental data, real world data is more robust in terms of predicting outcomes, once inconsistancies are weeded out.

7. To, Every New Frontline Manager by K. Hariram

An open letter to every new Frontline Manager, in verse.

Hot this week

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

Will TATA Succeed in Reinventing Indian Pharma Retail through 1 MG Hybrid?

Tata 1mg App Business Model: How does it work...

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...

Indian Pharma Market Performance – April 2025

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The Future in Your Palm+Chemistry – Palmistry

The future in your palm - a non-contact wearable...

Topics

Novo Nordisk — Septerna’s $2.2 Billion Deal

A New Era for Obesity Pills Novo Nordisk has announced...

GSK Bets Big on Liver Disease: $1.2B Upfront for Boston Pharma’s MASH Drug

In a bold move to strengthen its hepatology pipeline,...

Indian Pharma Market Performance – April 2025

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The Future in Your Palm+Chemistry – Palmistry

The future in your palm - a non-contact wearable...

Nimesulide – Nice or Not Nise?

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...
spot_img

Related Articles

spot_imgspot_img